Brinavess
·
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Vernakalant hydrochloride
- Made by
- Advanz Pharma Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults: for non-surgery patients: atrial fibrillation </= 7 days duration; for post-cardiac surgery patients: atrial fibrillation </= 3 days duration.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Advanz Pharma Limited |
|---|---|
| Active substance | Vernakalant hydrochloride |
| Used in | Heart, blood pressure and circulation |
| Classification | C01BG11 · Heart, blood pressure and circulation |
| Authorised on | 2010-09-01 |
| Last updated by the regulator | 2025-05-19 |
| EMA product number | EMEA/H/C/001215 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).